High volume, specialised approaches, in-house manufacture of intra-ocular lenses, and cross subsidies from paying patients mean that two-thirds of the outpatient visits and surgeries performed at Aravind can be provided to the poor at no cost or at highly discounted rates.

Over 20 million patients have been treated in the last 30 years.